Evidence map›Paper›PMID 24929004›Full record

ArticleJournal of leukocyte biology2014

A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases.

Helena Janols, Caroline Bergenfelz, Roni Allaoui, Anna-Maria Larsson, Lisa Rydén, Sven Björnsson, Sabina Janciauskiene, Marlene Wullt, Anders Bredberg, Karin Leandersson

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of leukocyte biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04163705 (Immune Profile of Patients With Positive Blood Cultures and Multiple Organ Dysfunctions), which is not on this map. Cited by 110 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04163705 unknown statusnot on this mapstarted 2019, after this paper: background citation

Immune Profile of Patients With Positive Blood Cultures and Multiple Organ Dysfunctions

Typeobservational_patient_registrySponsorHospital El CruceRan2019 to 2020Enrolled40ConditionsSepsis, SevereArmsblood sample collection
3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 1 synthesis or guideline pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Myeloid-derived suppressor cells in sepsis: drivers of persistent immunosuppression and targets for precision immunotherapy.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Helena JanolsDepartments of Infectious Diseases, Center for Molecular Pathology, and.
Caroline BergenfelzCenter for Molecular Pathology, and.
Roni AllaouiCenter for Molecular Pathology, and.
Anna-Maria LarssonDepartment of Laboratory Medicine, Translational Cancer Research, Medicon Village, Lund University, Malmo, Sweden; and.
Lisa RydénSurgery, and.
Sven BjörnssonCytometry Laboratory and Department of Laboratory Medicine, Skane University Hospital, and.
Sabina JanciauskieneDepartment of Pulmonology, Hannover Medical School, Germany.
Marlene WulltDepartments of Infectious Diseases.
Anders BredbergMedical Microbiology.
Karin LeanderssonCenter for Molecular Pathology, and karin.leandersson@med.lu.se.
Lund University · SEMedizinische Hochschule Hannover · DESkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The causative microorganisms dictate the type of MDSC generated in sepsis patients, and a large proportion of PMN-MDSCs in gram-positive sepsis includes immunosuppressive myeloid blasts. MDSCs constitute a heterogeneous population of immature myeloid cells that potently suppress immune responses. They were identified originally in cancer patients and have since been reported to occur also in chronic inflammation, autoimmunity, and even bacterial infections. Human MDSCs are commonly divided into Mo-MDSCs and granulocytic (PMN-MDSCs) subtypes. To what extent the bona fide cancer MDSCs are representative of the proposed MDSCs found in other diseases is not well known. PMN-MDSCs have been found previously to be enriched among LDGs in density gradient-centrifuged blood. In this study, we analyzed potential MDSCs in sepsis patients with different causative microorganisms, using total peripheral blood compared with density gradient-centrifuged blood. We found a high frequency of typical CD14(+)HLA-DR(low) Mo-MDSCs in all sepsis patients, whereas the typical PMN-MDSCs, as well as a prominent CD14(low) PMN-MDSC-like population, appeared preferentially in gram-positive cases. The CD14(low) PMN-MDSC variant was demonstrated to suppress T cell proliferation in vitro via a ROS-dependent mechanism, to display an increased IL-10:TNF-α ratio, and to present with signs of immaturity: blast morphology and low cytokine levels. We conclude that a spectrum of cells with MDSC features is enriched in sepsis and that the microbial origin of sepsis contributes to the substantial interindividual patient variation in the MDSC pattern.

Indexed as

PhenotypeAdultAgedAged, 80 and overAntigens, SurfaceCytokinesFemaleGram-Positive Bacterial InfectionsGranulocytesHumansImmunophenotypingLeukocyte CountLymphocyte ActivationMaleMiddle AgedMyeloid CellsAntigens, SurfaceCytokinescancerCD11cCD14FicollgranulocyteMDSC

Identifiers

PMID24929004
OpenAlexW2139499938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.